about
Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience.Strategies to improve outcome of patients with hepatocellular carcinoma receiving a liver transplantationHepatocellular carcinoma: A comprehensive reviewEvolving role of Sorafenib in the management of hepatocellular carcinoma.Hepatocellular carcinoma in patients listed for liver transplantation: Current and future allocation policy and management strategies for the individual patient.Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival.Meeting report of the 2014 joint international congress of the International Liver Transplantation Society, Liver Intensive Care Group of Europe, and European Liver and Intestinal Association.
P2860
Q26998606-70677DEC-AA62-48CB-9C80-B8CF7A491655Q27005375-C07DE331-673A-4443-83E3-97B628EDD34BQ28087638-006F7BC8-4D85-4030-8938-D005360ABEF8Q33779864-D29EE63E-4ACD-4D00-B7F3-4FD7073D9F6CQ38604896-2E2F364A-6AA4-4874-B7EE-DD82EB942776Q38635611-4FAC222B-6B51-478C-8E6B-CDF930A1B910Q47723625-F9CD69C8-FF20-4F8F-8489-4D697779C1F3
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Sorafenib use in the transplant setting.
@en
type
label
Sorafenib use in the transplant setting.
@en
prefLabel
Sorafenib use in the transplant setting.
@en
P2093
P2860
P50
P356
P1476
Sorafenib use in the transplant setting.
@en
P2093
Alessandro Vitale
Anna Giacomin
Giulia Castelli
Marco Senzolo
P2860
P304
P356
10.1002/LT.23911
P577
2014-08-04T00:00:00Z